BIT 5.00% 1.9¢ biotron limited

Funding Structure, page-88

  1. 667 Posts.
    lightbulb Created with Sketch. 130
    What a slam dunk of a video. The presented results speak for themselves, BIT225 is historically well tolerated and results are noticeable in terms of days not months for any upcoming trials. The big thing for me was the applicability for Emergency Use Authorisation, this means there's no final FDA Approval path required, the FDA can allow immediate use on the general public. Massive. The funding should be courting BIT not the other way around.

    Having said that any familiar with SPL's FDA slam dunk with VivaGel..
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.